REGABATIN CRX
DEAD

Serial Number

86525391

Owner

Intellipharmaceutics Corp.

Filing Date

Feb 5, 2015

Add to watchlist:

No watchlists yet
View on USPTO

REGABATIN CRX Trademark

Serial Number: 86525391

REGABATIN CRX is a trademark filed by Intellipharmaceutics Corp. on February 5, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Intellipharmaceutics Corp. (35 trademarks)

405 Britannia Road East, Suite 106
Mississauga Ontario L4Z 3E7 , CA

Entity Type: 03

Trademark Details

Filing Date

February 5, 2015

Registration Date

Not Registered

Goods & Services

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis

Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 6, 2017 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 6, 2017 ABN2
UNDELIVERABLE MAIL - COURTESY COPY MAILED
Mar 10, 2017 UNDC
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 8, 2017 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 8, 2017 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 8, 2017 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 1, 2017 RCCK
UNDELIVERABLE MAIL - COURTESY COPY MAILED
Sep 9, 2016 UNDC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 26, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 26, 2016 GNSL
SUSPENSION LETTER WRITTEN
Aug 26, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2016 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 25, 2016 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 25, 2016 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 25, 2016 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 25, 2016 CNSI
ASSIGNED TO LIE
Jul 21, 2016 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 6, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 6, 2016 GNSL
SUSPENSION LETTER WRITTEN
Jan 6, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 24, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2015 CRFA
ASSIGNED TO LIE
Nov 23, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 4, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2015 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2015 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2015 CNRT
ASSIGNED TO EXAMINER
May 12, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 19, 2015 NWOS
NEW APPLICATION ENTERED
Feb 9, 2015 NWAP